Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease by Huaying Wang et al.
RESEARCH ARTICLE Open Access
Quantitative analysis of pathogens in the
lower respiratory tract of patients with
chronic obstructive pulmonary disease
Huaying Wang1, Xiao Gu1, Yuesong Weng2, Tao Xu1, Zhongming Fu1, Weidong Peng1 and Wanjun Yu1*
Abstract
Background : Bacterial infection of the lower respiratory tract is believed to play a major role in the pathogenesis
of chronic obstructive pulmonary disease (COPD) and acute exacerbations of COPD (AECOPD). This study
investigates the potential relationship between AECOPD and the load of six common bacterial pathogens in the
lower respiratory tract using real-time quantitative PCR (RT-qPCR) in COPD patients.
Methods: Protected specimen brush (PSB) and bronchoalveolar lavage fluid (BALF) samples from the lower
respiratory tract of 66 COPD patients and 33 healthy subjects were collected by bronchoscopy. The load of
Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Pseudomonos aeruginosa, Haemophilus
influenzeae, and Moraxella catarrhalis were detected by RT-qPCR.
Results: High Klebsiella pneumoniae, Pseudomonos aeruginosa, Haemophilus influenzeae and Moraxella catarrhalis
burden were detected by RT-qPCR in both PSB and BALF samples obtained from stable COPD and AECOPD
patients compared with healthy subjects. The load of the above four pathogenic strains in PSB and BALF samples
obtained from AECOPD patients were significantly higher compared with stable COPD patients. Finally, positive
correlations between bacterial loads and inflammatory mediators such as neutrophil count and cytokine levels of
IL-1β, IL-6 and IL-8, as well as negative correlations between bacterial loads and the forced expiratory volume in
one second (FEV1) % predicted, forced vital capacity (FVC) % predicted, and FEV1/FVC ratio, were detected.
Conclusions: These findings suggest that increased bacterial loads mediated inflammatory response in the lower
respiratory tract and were associated with AECOPD. In addition, these results provide guidance for antibiotic
therapy of AECOPD patients.
Background
Progressive and irreversible airflow obstruction are char-
acteristics of chronic obstructive pulmonary disease
(COPD), which are caused by chronic inflammation of
airways [1]. COPD is a major cause of morbidity and
mortality worldwide and is projected to become the
third leading cause of death by 2030 [2]. The major
therapeutic goal of COPD treatment is to prevent acute
exacerbations. However, available treatments for acute
exacerbations of COPD (AECOPD) are currently not
very effective [3]. Bacterial infections of the lower
respiratory tract are believed to play a major role in the
pathogenesis of AECOPD. Generally, nontypeable Hae-
mophilus influenzae, Streptococcus pneumoniae, and to a
lesser extent, Moraxella catarrhalis are the most fre-
quent species isolated by microbiological culture during
COPD exacerbations [4]. These organisms can often be
found colonizing the airways of COPD patients between
exacerbations [5]. Since many of these bacteria persist in
the airways of COPD patients, their presence may pro-
mote chronic inflammatory states that drives COPD
pathogenesis. However, information on the quantitative
analysis of bacterial burden in the lower respiratory tract
in stable COPD and AECOPD patients are quite limited.
Previous studies frequently analyzed bacteria in the re-
spiratory tract of patients by traditional microbiological
culture techniques. However, the current microbiological
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gold standard has a number of limitations, particularly
the lack of sensitivity and time-consuming culture;
which significantly impacts the treatment and manage-
ment of patients, and limits our understanding of the
development and progression of COPD [4]. Further-
more, bacterial cultures can lead to false-negative re-
sults, especially during concurrent antibiotic treatment.
A challenge in COPD diagnostics is to distinguish
disease-causing strains from colonizing strains. It has
been shown that for Streptococcus pneumoniae [6], the
load of many types of bacteria in the respiratory tract is
probably greater during infection than during carriage;
and therefore, quantitative methods would most likely
improve diagnostic quality.
In recent years, real-time quantitative PCR (RT-qPCR)
has emerged as a valuable tool for the quantitative and
rapid detection of various biological specimens in body
fluids [7, 8]. Guma et al. developed a RT-qPCR method
using primers and a TaqMan probe complementary to se-
quences in the omp P6 gene for rapid detection of Hae-
mophilus influenzeae, and their study concluded that P6
RT-qPCR is both sensitive and specific for identifying
Haemophilus influenzeae in respiratory secretions [9]. In
another study, the prevelance of Moraxella catarrhalis
was detected by RT-qPCR using primers and probes tar-
geting the copB gene, which provided a sensitive and reli-
able means of rapidly detecting and quantifying Moraxella
catarrhalis during lower respiratory tract infections; and
this may be applied to other clinical samples [10]. In
addition, some other common pathogenic bacteria in re-
spiratory tract infections such as Klebsiella pneumoniae
[11], Staphylococcus aureus [12], Streptococcus pneumo-
niae [13], and Pseudomonos aeruginosa [14] were detected
by RT-qPCR, targeting bacteria-specific genes. These
methods present sensitive and reliable means of rapidly
detecting and quantifying microorganisms. The load of
common bacteria in the respiratory tract of patients with
COPD or lower respiratory tract infection was analyzed by
RT-qPCR or multiplex PCR in sputum samples [4, 15]. In
another study, the spectrum of potentially pathogenic
microorganisms in sputum of COPD patients was deter-
mined by PCR-denaturing gradient gel electrophoresis
(DGGE) [16]. However, most of these previous studies
focused on the respiratory tract microbiome of COPD
patients in the stable stage [17], and only few studies
compared common bacteria between the stable stage and
acute exacerbations of COPD. Furthermore, most of the
studied samples were sputum or bronchoalveolar lavage
fluid (BALF) samples, in which contamination by patho-
gens colonizing the upper respiratory tract are difficult to
avoid. Therefore, proper collection of samples from the
lower respiratory tract is a key for the precise quantitative
analysis of pathogens. The usefulness of a protected speci-
men brush (PSB) for diagnosing respiratory infections has
been reported earlier [18–20]. The tip of the sampling
brush or PSB is covered by a sheath to avoid contamin-
ation by organisms in the upper tract while the brush is
being inserted or pulled out [21]. Thus, PSB or protected
BALF from bronchoscopy appears as the best choice for
sample collection from the lower respiratory tract in
COPD patients.
In this present study, we describe the application of
RT-qPCR in tageting specific bacterial pathogen genes
for the simultaneous and direct detection and quantifica-
tion of a range of the most common pathogens in the
lower respiratory tract including Staphylococcus aureus,
Klebsiella pneumoniae, Streptococcus pneumoniae,
Pseudomonos aeruginosa, Haemophilus influenzeae, and
Moraxella catarrhalis in PSB and BALF samples obtained
from stable COPD and AECOPD patients. Moreover, we
explored the relationship among bacterial burden,
inflammtory response such as neurotophil count and
cytokine levels of IL-1β, IL-6 and IL-8 in BALF, and the
forced expiratory volume in one second (FEV1) % pre-
dicted, forced vital capacity (FVC) % predicted, and
FEV1/FVC lung function values in COPD patients. Our
study is the first to describe common bacteria in the
lower respiratory tract by RT-qPCR analysis using PSB
and protected BALF samples, and compare the change
of bacterial load between the stable stage and acute
exacerbations of COPD. These results may provide guid-




Sixty-six COPD patients (GOLD stage II-III, COPD
group) and 33 healthy subjects (HS group) with normal
pulmonary function (non-smokers) were enrolled in
this case–control study, which was carried out at the
Department of Respiratory Diseases, Affiliated Yinzhou
Hospital, College of Medicine, Ningbo University,
China. COPD was diagnosed according to the patient’s
history of tobacco smoking, symptoms, and post-
bronchodilator pulmonary function tests with FEV1/
FVC lower than 70 %, according to Global Initiative for
Chronic Obstructive Lung Disease (GOLD) guidelines
[22]. All patients were clinically assessed including
chest radiography, temperature recording and blood
gas analysis (as needed) to exclude other causes of
breathlessness. Moreover, patients in the COPD group
were further divided into two subgroups according to
disease stage: stable COPD group and AECOPD group.
The stable COPD group consisted of 34 patients who
were evaluated as clinically stable and underwent an
exacerbation-free period of six weeks. Patients in the
stable COPD and HS groups were examined by bron-
choscopy to exclude other lung lesions. The AECOPD
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group consisted of 32 patients who were identified ac-
cording to the Anthonisen criteria [23] and the consen-
sus definition for COPD exacerbations [24]. Patients in
the AECOPD group were diagnosed according to pul-
monary function and underwent mechanical ventilation
via tracheal tubing to treat type-II respiratory failure.
Bronchoscope examinations were guided by a tracheal
tube. All subjects enrolled in this study underwent
routine blood examination. Patients that presented
with pneumonia, neuromuscular diseases, thoracic de-
formities, restrictive lung diseases, pulmonary vascular
disease, as well as patients who underwent lung resec-
tion, were excluded from this study. Two hours after
tracheal tube intubation and before antibiotic treat-
ment, lower respiratory tract samples were collected by
a protected specimen brush (PSB) and protected bron-
choalveolar lavage (BAL) during bronchoscopy. This
study protocol was authorized by the ethics and re-
search committee of the Affiliated Yinzhou Hospital,
College of Medicine, Ningbo University, China. Signed
informed consent was obtained from all subjects.
Collection of PSB and BALF samples from patients
PSB samples were collected with a sheath brush (Olympus
BC-5 CE, Olympus Imaging, Center Valley, PA, USA) with
a distal occlusion composed of polyethylene glycerol
through a flexible bronchoscope (Olympus, BF-260). The
brush was pushed out of the sheath, cut with ethanol-
disinfected scissors, and placed in an Eppendorf tube con-
taining 1.5 ml of saline solution. A part of the PSB samples
(0.5 ml) were used for standard bacterial cultures and
remaining samples were prepared for total DNA extrac-
tion. Simultaneously with PSB sample collection, BAL
specimens were obtained by lavaging the airway with ap-
proximately 50 ml of 0.9 % NaCl solution through the
bronchoscope; and approximately 60 % lavage return vol-
ume was collected. Total BALF cells were counted from a
0.05 ml aliquot, 0.5 ml of BALF samples were used for
bacterial cultures, and 1 ml of BALF samples were taken
for total DNA extraction. Remaining fluid samples were
centrifuged (1,000 g for 10 min) at 4 °C, and the super-
natant was stored at −80 °C for subsequent cytokine ana-
lysis by ELISA. The remaining cell pellets were
resuspended with 0.9 % NaCl solution, and a differen-
tial cell count was performed using cytospin and
Wright-Giemsa staining.
Bacterial cultures
PSB and BALF samples were inoculated into Eosin
methylene blue agar, Brucella agar, blood agar, and choc-
olate agar media (Biomérieux, Marcy l'Etoile. France);
and incubated for 24–48 h at 37 °C. Colony identifica-
tion was performed using the Vitek 2 Compact full auto-
matic identification system (Biomérieux, France). For
PSB and BALF cultures, after 24 h of incubation, bacter-
ial colonies with growth of ≥103 and ≥105, respectively,
were considered as pathogenic.
Cytokine ELISA
IL-1β, IL-6, IL-8, IL-10 and TNF-α cytokine concentra-
tions in BALF supernatants were measured by standard-
ized sandwich ELISA (eBioscience, San Diego, CA, USA)
according to manufacturer’s protocols.
Preparation of bacterial DNA from PSB and BALF samples
PSB or BALF samples (1 ml) were centrifuged at
11,000 g for five minutes. Aliquots of 0.2 ml of the pellet
were used in order to obtain a 5-fold concentration of
the samples. DNA was prepared using a Qiagen DNA
Mini Kit (Qiagen, Hilden, Germany) according to manu-
facturer’s instructions. DNA was stored at −20 °C before
amplification by RT-qPCR. In each experiment, a nega-
tive control that contained all reagents except the PSB
sample was included.
RT- qPCR of PSB and BALF samples
Primers and TaqMan probes for the specific amplifica-
tion of Staphylococcus aureus, Klebsiella pneumoniae,
Streptococcus pneumoniae, Pseudomonos aeruginosa,
Haemophilus influenzeae and Moraxella catarrhalis
were synthesized by Sangon Biotech Co., Ltd. (Shanghai,
P.R. China). Primer sequences and assay performance
are summarized in Table 1. DNA amplification and de-
tection were performed with a TaqMan 7500 Fast system
(Applied Biosystems, Foster City, CA, USA). The reac-
tion mixture (20 μl) used in the PCR assay was as fol-
lows: 10 μl of TaqMan Universal PCR Mastermix
(Applied Biosystems), 2 μl of extracted DNA, 0.5 μl of
specific primers (final concentration was 0.6 μmol/l),
and probes (final concentration was 0.3 μmol/l). PCR
cycling conditions applied for khe, cps, omp P6, and
copB gene assays were as follows: heating at 94 °C for
four minutes, followed by 40 cycles of 94 °C for 30 s and
60 °C for one minute. PCR cycling conditions applied
for egc and gyrB gene assays were as follows: heating at
95 °C for 10 min, followed by 45 cycles of 95 °C for 15 s
and 60 °C for one minute. Optimized conditions of the
RT-qPCR assay are summarized in Table 2. Fluorescence
was measured after each cycle, and each assay was car-
ried out in duplicate. Two negative RT-qPCR controls
were run on each sample plate, and the median cycle of
quantification (Cq) value from each duplicate was used
for analysis.
Quantification of microorganism load in PSB and BALF
samples
To quantify the number of bacterial cells in PSB and
protected BALF samples, six ATCC standard strains
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were used as positive controls. Staphylococcus aureus
(ATCC 25923) and Pseudomonos aeruginosa (ATCC
27853) were provided by the Clinical Laboratory, First
Hospital, Ningbo City, China. Klebsiella pneumoniae
(ATCC 700603), Streptococcus pneumoniae (ATCC
49619), Haemophilus influenzeae (ATCC 49247), and
Moraxella catarrhalis (ATCC 25238) were purchased
from Bioplus Biotech Co., Ltd. (Shanghai, China). A
dense suspension of bacteria grown on agar plates was
inoculated in phosphate-buffered saline, representing
a bacterial concentration of approximately 108 CFU/
ml. A 10-fold serial dilution scheme ranging between
108 and 103 CFU/ml was prepared. To correlate cycle
threshold (CT) values measured by RT-qPCR with the
number of bacterial cells present in each sample, ali-
quots (100 ml) of each dilution of bacterial suspension
were plated out in triplicate onto agar plates. Agar
plates were incubated overnight at 37 °C, and colonies
were counted in order to calculate the number of CFU
per dilution tube. DNA extraction was performed
from a sample (5 ml) of each dilution tube and was
analyzed concomitantly by RT-qPCR. Each positive
control was carried out in triplicate, mean CT values were
calculated and plotted against the base 10 logarithm of
Table 1 RT-qPCR primers and assay performance summary
Organism Target gene Primer/Probe sequences Assay linearity Ref.
Staphylococcus aureus egc F:5′-CTTCATATGTGTTAAGTCTTGCAGCTT-3′ R2 = 0.995 [12]
R:5′-TTCACTCGCTTTATTCAATTGTTCTG-3′ Slope = −3.91
P: 5′-6-FAM -ATGTTAAATGGCAATCCT-TAMRA -3′ Efficiency = 1.04
Klebsiella pneumoniae khe F: 5′-GATGAAACGACCTGATTGCATTC-3′ R2 = 0.997 [11]
R: 5′-CCGGGCTGTCGGGATAAG-3′ Slope = −3.60
P:5′-6-FAM-CGCGAACTGGAAGGGCCCG-TAMRA-3′ Efficiency = 1.07
Streptococcus pneumoniae cps F: 5′-GCTGTTTTAGCAGATAGTGAGATCGA-3′ R2 = 0.995 [13]
R: 5′-TCCCAGTCGGTGCTGTCA-3′ Slope = −3.11
P: 5′-6-FAM-AATGTTACGCAACTGACGAG-TAMRA -3′ Efficiency = 1.12
Pseudomonos aeruginosa gyrB F: 5′-GGCGTGGGTGTGGAAGTC-3′ R2 = 0.995 [14]
R: 5′-TGGTGGCGATCTTGAACTTCTT-3′ Slope = −3.55
P: 5′-6-FAM-TGCAGTGGAACGACA-TAMRA-3′ Efficiency = 0.96
Haemophilus influenzeae omp P6 F:5′-CCAGCTGCTAAAGTATTAGTAGAAG-3′ R2 = 0.997 [9]
R: 5′-TTCACCGTAAGATACTGTGCC-3′ Slope = −4.22
P: 5′-6-FAM -CAGATGCAGTTGAAGGTTATTTAG- Efficiency = 0.95
TAMRA-3′
Moraxella catarrhalis copB F: 5′-GTGAGTGCCGCTTTACAACC-3′ R2 = 0.998 [10]
R: 5′-TGTATCGCCTGCCAAGACAA-3′ Slope = −3.66
P:5′-6-FAM-TGCTTTTGCAGCTGTTAGCCAGCCTAA- Efficiency = 0.91
TAMRA-3′
Table 2 Optimized conditions for egc, khe, cps, gyrB, omp P6 and copB RT-qPCR assay
Reaction Final concentration
Components egc khe cps gyrB omp P6 copB
TaqMan Universal PCR Mastermix 1× 1× 1× 1× 1× 1×
Primer 0.6 μmol/L 0.6 μmol/L 0.6 μmol/L 0.6 μmol/L 0.6 μmol/L 0.6 μmol/L
Probe 0.3 μmol/L 0.3 μmol/L 0.3 μmol/L 0.3 μmol/L 0.3 μmol/L 0.3 μmol/L
Total volume 20 μl 20 μl 20 μl 20 μl 20 μl 20 μl
Melt 95 °C, 10 min 94 °C, 4 min 94 °C, 4 min 95 °C, 10 min 94 °C, 4 min 94 °C, 4 min
Denaturation 95 °C, 15 s 94 °C, 30 s 94 °C, 30 s 95 °C, 15 s 94 °C, 30 s 94 °C, 30 s
Annealing/Extension 60 °C, 60 s 60 °C, 60 s 60 °C, 60 s 60 °C, 60 s 60 °C, 60 s 60 °C, 60 s
Cycles 45 40 40 45 40 40
PCR Product Size 82 base pairs 77 base pairs 67 base pairs 190 base pairs 156 base pairs 71base pairs
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CFU per ml, and a standard curve was generated. The load
of microorganisms in PSB and BALF samples was deter-
mined using a standard equation.
Statistical analysis
All data were expressed as means ± SEM. Differences be-
tween groups were examined for statistical significance
by one-way analysis of variance (ANOVA) using SPSS
11.0 software (SPSS Inc., Chicago, USA). The correlation
among bacterial burden, inflammatory mediators such
as neutrophil cell count and cytokine levels, and pul-
monary function such as FEV1 % predicted, FVC % pre-
dicted, and FEV1/FVC were calculated using Pearson’s
correlation coefficient. P values <0.05 denoted that the
difference was statistically significant.
Results
Demographic and clinical features and pulmonary
function of COPD patients and healthy subjects (HS)
Demographic and clinical features, spirometric findings,
and routine blood examination results of patients in the
HS, stable COPD and AECOPD groups are shown in
Table 3. Age, gender, and BMI did not differ among the
three groups. Spirometry, FVC, FVC % predicted, FEV1,
and FEV1 % predicted significantly decreased in patients
in the stable COPD group compared with patients in the
HS group (P < 0.05). However, the percentage of neutro-
phils and C-reactive protein (CRP) levels were significantly
higher in patients in the stable COPD and AECOPD
groups compared with patients in the HS group (P < 0.05),
and between patients in the stable COPD and AECOPD
groups (P < 0.01). White blood cell count significantly
increased in patients in the AECOPD group compared with
patients in the stable COPD and HS groups (P < 0.01).
However, there was no significant difference between pa-
tients in the stable COPD and HS groups (P > 0.05).
Microbiological cultures from PSB and BALF samples
obtained from COPD patients and HS
PSB and BALF samples were obtained through a flexible
bronchoscope to analyze bacteria in the lower respira-
tory tract of COPD patients and HS. Microbiological
cultures revealed that 29 HS (87.9 %) had no isolated or
normal non-pathogenic bacterial flora in PSB and BALF
samples (Table 4). In 20 (58.8 %) and 15 COPD patients
(44.1 %), no isolated or normal airway bacterial flora was
detected in PSB and BALF samples, respectively. In nine
(28.1 %) and eight (25.0 %) AECOPD patients, no isolated
or normal airway bacterial flora was detected in PSB and
BALF samples, respectively. The following pathogenic bac-
teria were identified in cultures of the remaining patients:
Staphylococcus aureus, Klebsiella pneumoniae, Streptococ-
cus pneumoniae, Pseudomonos aeruginosa, Haemophilus
influenzeae, and Moraxella catarrhalis. Other isolated bac-
teria included Acihetobacter baumanii, Escherichia coli, and
Streptococcus hemolyticus (Table 4).
RT-qPCR analysis of bacteria in PSB and BALF samples
obtained from COPD patients and HS
Total bacterial DNA in PSB and BALF samples were
extracted for quantification of bacterial content by
RT-qPCR analysis. Six bacterial strains were analyzed
using corresponding standard strains as positive
controls (Table 5). Staphylococcus aureus, Klebsiella
pneumoniae, Streptococcus pneumoniae, Pseudomonos
Table 3 Demographic and clinical characteristics of patients in the HS, stable COPD and AECOPD groups
HS Stable COPD patients AECOPD patients
(n = 33) (n = 34) (n = 32)
Age (years) 65 ± 8 67 ± 7 69 ± 6
Gender (M/F) 20/13 28/6 27/5
BMI (kg/m2) 23.1 ± 5.1 24.2 ± 4.9 23.8 ± 3.9
Tobacco (pack/year) - 44.2 ± 25.6 43.7 ± 27.8
FEV1 (L) 3.3 ± 0.3 1.3 ± 0.1** 1.2 ± 0.2**
FEV1 % predicted 103.6 ± 7.3 53.4 ± 8.8** 51.4 ± 9.0**
FVC (L) 4.0 ± 0.2 2.9 ± 0.2* 2.7 ± 0.2*
FVC % predicted 102.7 ± 6.7 81.4 ± 9.3** 79.9 ± 7.4**
FEV1/FVC (%) 82.3 ± 6.1 43.8 ± 4.4** 44.1 ± 7.1**
WBC (x109/L) 5.6 ± 1.2 6.1 ± 1.7 11.4 ± 5.1**##
Neutrophils (%) 64.6 ± 6.7 68.7 ± 7.6* 85.4 ± 6.1**##
CRP (mg/L) 6.7 ± 2.4 16.1 ± 6.7** 85.2 ± 30.4**##
All data are expressed as means ± SEM, except gender. *P < 0.05 and **P < 0.01 vs. the HS group; #P < 0.05 and ##P < 0.01 vs. the stable COPD group; FEV1, Forced
expiratory volume in one second; FVC, forced vital capacity; CRP, C-reactive protein; HS, Healthy subjects. The spirometry data in AECOPD patients reflect the base-
line data in the stable stage
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aeruginosa, Haemophilus influenzeae, and Moraxella
catarrhalis were recovered from PSB samples in 68.8 %,
46.9 %, 42.8 %, 62.5 %, 78.1 % and 50.0 % of patients in the
AECOPD group, respectively; and in 47.1 %, 29.4 %, 58.8 %,
44.1 %, 52.9 % and 64.7 % of patients in the stable COPD
group, respectively; compared with 9.1 %, 15.2 %, 30.3 %,
6.1 %, 15.2 % and 12.1 % of HS, respectively (P < 0.01). De-
tected rates of the six strains in BALF samples demon-
strated the same diversification trend as those revealed in
PSB samples. There was no significant difference in detec-
tion rates for the six bacterial strains in BALF samples com-
pared with PSB samples (Table 5).
Furthermore, to compare the pathogen detection rate be-
tween microbiological culture and RT-qPCR, mean detec-
tion rates of the six pathogens by RT-qPCR analysis and
conventional microbiological culture from PSB and BALF
samples in all subjects were calculated and analyzed. Mean
detection rates of Staphylococcus aureus, Klebsiella
pneumoniae, Streptococcus pneumoniae, Pseudomonos
aeruginosa, Haemophilus influenzeae, and Moraxella
catarrhalis by RT-qPCR analysis were 40.6 ± 36.79 %,
31.03 ± 14.5 %, 43.68 ± 13.87 %, 32.62 ± 30.78 %, 49.7 ±
27.28 % and 40.77 ± 23.08 %, respectively; which were sig-
nificantly higher compared with 7.08 ± 3.68 % (P = 0.008),
7.14 ± 4.74 % (P = 0.001), 10.07 ± 3.58 % (P = 0.0002),
6.15 ± 6.57 % (P = 0.022), 8.18 ± 7.84 % (P = 0.0018),
and 3.07 ± 2.82 % (P = 0.0037), respectively, as detected
by conventional culture methods.
Quantification of microorganism load in PSB and BALF
samples obtained from COPD patients and HS
To quantify the number of bacterial cells in PSB and
protected BALF samples obtained from patients in the
three groups, six ATCC standard strains (Staphylococcus
aureus, Klebsiella pneumoniae, Streptococcus pneumo-
niae, Pseudomonos aeruginosa, Haemophilus influenzeae,
and Moraxella catarrhalis) were used as positive con-
trols to correlate CFU with the CT values measured by
RT-qPCR. CT values revealed a linear correlation with
the 10-log of CFU per ml of bacteria. Therefore, the load
of pathogens in PSB and BALF samples were calculated
according to a standard curve equation (Fig. 1). A sig-
nificant increase in the load of Staphylococcus aureus,
Table 5 RT-qPCR analysis of PSB and BALF samples obtained from patients in the HS, stable COPD and AECOPD groups
n (%) HS Stable COPD patients AECOPD patients
(n = 33) (n = 34) (n = 32)
PSB BALF PSB BALF PSB BALF
Staphylococcus aureus 3 (9.1) 2 (6.1) 16 (47.1) 17 (50.0) 22 (68.8) 20 (62.5)
Klebsiella pneumoniae 5 (15.2) 6 (18.2) 10 (29.4) 9 (26.5) 15 (46.9) 16 (50.0)
Streptococcus pneumoniae 10 (30.3) 8 (24.2) 20 (58.8) 18 (52.9) 14 (42.8) 17 (53.1)
Pseudomonos aeruginosa 2 (6.1) 2 (6.1) 15 (44.1) 17 (50.0) 20 (62.5) 23 (71.9)
Haemophilus influenzeae 5 (15.2) 6 (18.2) 18 (52.9) 20 (58.8) 25 (78.1) 24 (75.0)
Moraxella catarrhalis 4 (12.1) 4 (12.1) 22 (64.7) 20 (58.8) 16 (50.0) 15 (46.9)
HS, Healthy subjects
Table 4 Microbiological culture results of PSB and BALF samples obtained from patients in the HS, stable COPD and AECOPD
groups
n (%) HS Stable COPD patients AECOPD patients
(n = 33) (n = 34) (n = 32)
PSB BALF PSB BALF PSB BALF
No isolated or Normal flora 29 (87.9) 29 (87.9) 20 (58.8) 15 (44.1) 9 (28.1) 8 (25.0)
Staphylococcus aureus 1 (3.0) 1 (3.0) 2 (5.9) 4 (11.8) 3 (9.4) 3 (9.4)
Klebsiella pneumoniae 1 (3.0) 1 (3.0) 1 (2.9) 3 (8.8) 4 (12.5) 4 (12.5)
Streptococcus pneumoniae 2 (6.0) 2 (6.0) 4 (11.8) 5 (14.7) 3 (9.4) 4 (12.5)
Pseudomonos aeruginosa 0 0 2 (5.9) 2 (2.9) 4 (12.5) 5 (15.6)
Haemophilus influenzeae 0 0 2 (5.9) 3 (8.8) 6 (18.8) 5 (15.6)
Moraxella catarrhalis 0 0 1 (2.9) 2 (2.9) 2 (6.3) 2 (6.3)
Othersa 0 0 1 (2.9) 2 (2.9) 1 (3.1) 1 (3.1)
aOther isolated bacteria including Acinetobacter baumanii, Escherichia coli, and Streptococcus hemolyticus. HS, Healthy subjects
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Klebsiella pneumoniae, Pseudomonos aeruginosa, Hae-
mophilus influenzeae, and Moraxella catarrhalis in PSB
samples obtained from AECOPD patients were detected,
as compared with PSB samples obtained from stable
COPD patients (Fig. 2a, P < 0.01 or P < 0.05). The load of
Klebsiella pneumoniae and Haemophilus influenzea in
PSB samples obtained from AECOPD patients signifi-
cantly increased compared with PSB samples obtained
from the HS group (P < 0.01). However, there was no
significant difference in the load of Streptococcus pneu-
moniae between patients in the COPD and HS groups
(P > 0.05).
There was a significant increase in the load of Klebsi-
ella pneumoniae, Pseudomonos aeruginosa, Haemophi-
lus influenzeae, and Moraxella catarrhalis in BALF
samples obtained from AECOPD patients compared
with BALF samples obtained from stable COPD pa-
tients (Fig. 2b, P < 0.01 or P < 0.05). Moreover, the load
of Haemophilus influenzea in BALF samples obtained
from AECOPD patients significantly increased, com-
pared with BALF samples obtained from patients in the
HS group (P < 0.05). However, there was no significant
difference in the load of Staphylococcus aureus and
Streptococcus pneumoniae between patients in the
COPD and HS groups (P > 0.05).
Total and differential cell counts in BALF samples
obtained from COPD patients and HS
To assess the degree of lung inflammation in COPD
patients, BALF samples were collected; then, total and
differential cell counts were analyzed. The total number
of alveolar inflammatory cells dramatically increased in
AECOPD patients compared with stable COPD patients
and HS, and in stable COPD patients compared with
HS (P < 0.01, Fig. 3a).
The differential cell count of BALF revealed a sig-
nificant increase in all inflammatory cells in the alveo-
lar space in AECOPD patients compared with stable
Fig. 1 Standard curves for Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus pneumoniae, Pseudomonos aeruginosa, Haemophilus
influenzeae, and Moraxella catarrhalis assays. Mean threshold cycle (CT) value ± SEM of three replicates (three per run) for each reaction is shown
in relation to the log of CFU calculated per 20 μl of reaction mixture. Relative correlation coefficient (R2) and linear regression equations are
reported in the legend
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COPD patients and HS (Fig. 3b). The highest increment
was observed in the neutrophil population (P < 0.01),
but the number of lymphocytes and macrophages also
significantly increased in AECOPD patients (P < 0.01).
However, the percentage of macrophages in the total cell
population significantly decreased (P < 0.01). The per-
centage of lymphocytes in stable COPD and AECOPD
patients significantly increased compared with HS (P
< 0.01, Fig. 3b).
Cytokine levels in BALF supernatants obtained from
COPD patients and HS
In order to determine changes in pro-inflammatory cyto-
kines, BALF supernatants obtained from COPD patients
and HS were collected. IL-1β, IL-6, IL-8, IL-10 and TNF-α
were measured by ELISA. Levels of IL-1β, IL-6, IL-8, IL-10
and TNF-α in BALF supernatants were significantly higher
in stable COPD and AECOPD patients compared with HS
(Table 6, P < 0.01). Moreover, significant differences were
Fig. 2 Bacterial load in PSB and BALF samples obtained from COPD patients and healthy subjects. The burden of Staphylococcus aureus, Klebsiella
pneumoniae, Pseudomonos aeruginosa, Haemophilus influenzeae, and Moraxella catarrhalis in PSB samples (a), and of Klebsiella pneumoniae,
Pseudomonos aeruginosa, Haemophilus influenzeae, and Moraxella catarrhalis in BALF samples (b) obtained from AECOPD patients compared with
stable COPD patients. All data are expressed as means ± SEM. *P < 0.05 and **P < 0.01 vs. the HS group; #P < 0.05 and ##P < 0.01 vs. the stable
COPD group
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observed between stable COPD and AECOPD patients for
all cytokines (P < 0.01).
Correlation between bacterial burden, inflammatory
index, and pulmonary function of COPD patients and HS
Using Pearson’s correlation coefficient, positive correla-
tions were detected between the load of Klebsiella
pneumoniae, Pseudomonos aeruginosa, Haemophilus
influenzeae and Moraxella catarrhalis, and inflamma-
tory mediators such as the percentage of neutrophils
and concentration of cytokines such as IL-1β, IL-6 and
IL-8 in BALF supernatants (Table 7). Moreover, Pear-























































Fig. 3 Infiltration of inflammatory cells in airways of COPD patients. The number of total inflammatory cells including neutrophils, lymphocytes,
and macrophages in BALF samples obtained from patients in the HS, stable COPD and AECOPD groups were determined (a). The percentage of
each cell type from total cells (b). Data are expressed as means ± SEM (n = 20 per group). *P < 0.05 and **P < 0.01 vs. the HS group; #P < 0.05 and
##P < 0.01 vs. the stable COPD group
Table 6 Cytokine levels in BALF supernatants obtained from
patients in the HS, stable COPD and AECOPD groups
Cytokines
(pg/ml)
HS Stable COPD patients AECOPD patients
(n = 33) (n = 34) (n = 32)
IL-1β 0.15 ± 0.05 0.21 ± 0.07** 0.58 ± 0.13**##
IL-6 0.64 ± 0.15 1.05 ± 0.21** 2.07 ± 0.22**##
IL-8 6.81 ± 1.59 9.50 ± 1.3** 31.39 ± 6.02**##
IL-10 0.10 ± 0.06 0.18 ± 0.06** 0.30 ± 0.10**##
TNF-α 0.02 ± 0.01 0.05 ± 0.01** 0.27 ± 0.11**##
All data are expressed as means ± SEM. *P < 0.05 and **P < 0.01 vs. the HS
group; #P < 0.05 and ##P < 0.01 vs. the stable COPD group. HS, Healthy subjects
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Staphylococcus aureus, Pseudomonos aeruginosa, Hae-
mophilus influenzeae and Moraxella catarrhalis, and
TNF-α concentrations in BALF supernatants revealed
a positive and statistically significant correlation (P <
0.01). However, no significant correlation between the
load of Streptococcus pneumoniae and inflammatory
mediators was detected (P > 0.05).
The correlation between the load of the six pathogens
and the FEV1 % predicted, FVC % predicted and FEV1/
FVC values were analyzed to assess the relationship be-
tween bacterial burden and pulmonary function in the
study subjects. Pearson’s correlation coefficients between
the load of Staphylococcus aureus, Klebsiella pneumoniae,
Streptococcus pneumoniae, Pseudomonos aeruginosa, Hae-
mophilus influenzeae and Moraxella catarrhalis in PSB
samples and the FEV1 % predicted, FVC % predicted, and
FEV1/FVC values revealed a negative statistically signifi-
cant correlation (P < 0.01, Table 8).
Discussion
Several innate immune mechanisms are involved in
maintaining the sterility of a healthy human airway.
However, immune mechanisms are disrupted by smok-
ing or other hazardous substances; resulting in the per-
sistence of microbial pathogens in the lower airway of
COPD patients [25], which is called “colonization” by
some researchers. Previous studies have proven that bac-
terial colonization is associated with greater levels of air-
way inflammation measured in sputum [26–28] and has
been implicated as the cause of most exacerbations in
COPD [29–31]. Acute exacerbations are associated with
a more rapid decline in lung function and an impaired
quality of life, which are both major causes of morbidity
and mortality in COPD [22]. However, the pathogens in-
volved, the number of pathogens that change, and the
mechanism on how these infections alter lower airway
inflammation remains unclear.
Bacterial colonization and airway inflammation in
COPD patients have been previously demonstrated in
studies. However, these studies have been limited to
sampling the central tracheobronchial tree and/or de-
tecting the pathogen by traditional cultures [26–28]. In
this present study, the load of pathogenic bacteria
strain Staphylococcus aureus, Klebsiella pneumoniae,
Streptococcus pneumoniae, Pseudomonos aeruginosa,
Haemophilus influenzeae and Moraxella catarrhali
were detected in PSB and BALF samples obtained from
COPD patients and HS by RT-q-PCR assays, targeting
specific pathogen genes. Moreover, cell count in BALF
and pro-inflammatory cytokine concentrations in BALF
supernatants were analyzed. Significantly higher levels
of Klebsiella pneumoniae, Pseudomonos aeruginosa,
Haemophilus influenzeae, and Moraxella catarrhalis
were identified in both PSB and BALF samples obtained
from stable COPD and AECOPD patients. Additionally,
a significantly higher number of total cells and percent-
age of neutrophils in BALF, together with higher levels
of IL-1 β, IL-6, IL-8, IL-10 and TNF-α in BALF super-
natants, were detected in stable COPD and AECOPD
patients. More importantly, pathogen loads in BALF
samples were positively correlated with the percentage
of neutrophils and levels of pro-inflammatory cytokines













(log CFU/ml) (log CFU/ml) (log CFU/ml) (log CFU/ml) (log CFU/ml) (log CFU/ml)
r p r p r p r p r p r p
Neutrophil (%) 0.175 0.252 0.458 0.002 0.071 0.641 0.497 0.003 0.564 <0.01 0.551 <0.01
IL-1β (pg/ml) −0.082 0.511 0.327 0.010 0.086 0.479 0.452 0.001 0.682 <0.01 0.503 <0.01
IL-6 (pg/ml) 0.068 0.589 0.317 0.012 0.082 0.500 0.413 0.004 0.663 <0.01 0.549 <0.01
IL-8 (pg/ml) 0.165 0.187 0.314 0.013 0.044 0.720 0.341 0.018 0.694 <0.01 0.587 <0.01
IL-10 (pg/ml) −0.042 0.738 0.201 0.118 0.110 0.364 0.205 0.163 0.451 <0.01 0.376 0.003
TNF- α (pg/ml) 0.266 0.031 0.249 0.051 0.121 0.316 0.320 0.027 0.703 <0.01 0.493 <0.01













(log CFU/ml) (log CFU/ml) (log CFU/ml) (log CFU/ml) (log CFU/ml) (log CFU/ml)
r p r p r p r p r p r p
FEV1 % predicted −0.674 <0.01 −0.865 <0.01 −0.543 <0.01 −0.664 <0.01 −0.849 <0.01 −0.813 <0.01
FVC % predicted −0.597 <0.01 −0.756 <0.01 −0.419 <0.01 −0.586 <0.01 −0.728 <0.01 −0.675 <0.01
FEV1/FVC −0.660 <0.01 −0.833 <0.01 −0.532 <0.01 −0.639 <0.01 −0.814 <0.01 −0.776 <0.01
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in BALF. Pathogen loads in PSB samples were nega-
tively correlated with FEV1 % predicted, FVC % pre-
dicted, and FEV1/FVC values. Thus, the increase of
pathogens in the lower respiratory tract likely contrib-
uted to the inflammatory response in the airways, lead-
ing to recurrent AECOPD and pulmonary function
decline.
Obtaining samples from the lower respiratory tract
without being contaminated by the upper airway flora is
a crucial factor in accurately determining the prevalence
of bacteria in the lower respiratory tract. Previous stud-
ies have found higher rates of bacterial isolates in spu-
tum than in samples collected by bronchoscopy in stable
COPD patients [32–34]. This is likely due to the high
contamination rate of sputum with the upper respiratory
tract flora. Therefore, bronchoscopy with PSB appears as
the best method to avoid upper airway contamination.
For the same reason, protected BALF samples are appro-
priate for contamination-free pathogen analysis. Our re-
sults did not reveal significant differences in rates of the
six analyzed pathogens between PSB and BALF samples
among the three study groups. However, significantly
higher rates of these six pathogens were found in PSB
and BALF samples obtained from COPD patients
compared with samples obtained from HS, and no sig-
nificant differences between stable COPD and AECOPD
patients were detected. These data confirms bacterial
colonization in the lower respiratory tract of COPD pa-
tients, regardless of the patient’s status (stable or acute
exacerbation of COPD). Nevertheless, persistent symp-
toms and recurrent exacerbations were seen in ex-
smokers with moderate to severe COPD, suggesting that
persistent inflammation resulting from bacterial infec-
tions has clinical consequences. Thus, the number of
bacteria in the airway is a key factor for the development
of AECOPD in stable COPD pateints.
Previous studies have demonstrated bacterial load
changes in airways of COPD patients using conventional
methods [26–29]. However, conventional methods such
as microbiological cultures are time-consuming and may
give false-negative results, especially during ongoing
antibiotic treatments. Non-culture based methods such
as RT-qPCR are sensitive, specific and provide fast re-
sults; and are valuable tools for the early diagnosis and
effective therapy of COPD. Erb-Downward et al. identified
a core pulmonary bacterial microbiome that includes
Pseudomonas, Streptococcus, Prevotella, Fusobacterium,
Haemophilus,Veillonella, and Porphyromonas by massively
parallel pyrosequencing of bacterial 16S amplicons [35]. In
another study, the composition of the lung microbiome
was determined using 454 pyrosequencing of 16S rDNA
in BALF; and found that the main phyla in all samples
were Actinobacteria, Firmicutes, and Proteobacteria [17].
However, analysis of microbiomes by 16S rDNA or 16 s
rRNA focuses in building a picture of the complete
microbial community in an environment, making a
cluster analysis and studying the evolution history of
microbiomes. Nevertheless, it is important to identify
common bacterial species in the lower respiratory
tract of COPD patients for guidance in clinical anti-
biotic therapy and analysis of inflammatory response.
In this present study, RT-qPCR analysis revealed sig-
nificantly higher detection rates for Staphylococcus
aureus, Klebsiella pneumoniae, Streptococcus pneumoniae,
Pseudomonos aeruginosa, Haemophilus influenzeae, and
Moraxella catarrhalis, compared to conventional microbio-
logical culture in all subjects. These results reflect the
higher sensitivity and specificity of RT-qPCR, as a fast
pathogen detection method.
Pathogens such as Streptococcus pneumoniae, Hae-
mophilus influenzae, and Moraxella catarrhalis are asso-
ciated with approximately 50 % of COPD exacerbations,
as demonstrated by traditional microbiological culture.
These organisms can often be found colonizing the re-
spiratory airways of COPD patients between exacerba-
tions [5], and are consistent with our culture results.
However, bacteria in COPD varies with disease severity,
as Pseudomonas aeruginosa is more commonly detected
in patients with severe COPD in both stable [36, 37] and
acute exacerbations [38–40]. Microbiome analysis by
16S rDNA or 16 s rRNA also revealed that Haemophilus
species were strongly associated with the presence of
COPD [41], while Pseudomonas species were more com-
monly observed in subjects with moderate or severe
COPD [35]. Patients in our present study presented with
moderate and severe COPD (GOLD stage II-III), and the
load of Klebsiella pneumoniae, Haemophilus influenzeae,
Moraxella catarrhalis and Pseudomonos aeruginosa in
PSB and BALF samples obtained from COPD patients
significantly increased compared with samples obtained
from HS, as detected by RT-qPCR; suggesting that bac-
terial species quantitatively analyzed by RT-qPCR are
consistent with bacterial species cultured in previous
studies. Moreover, the load of Klebsiella pneumoniae,
Haemophilus influenzeae, Moraxella catarrhalis and
Pseudomonos aeruginosa in AECOPD patients also sig-
nificantly increased compared with stable COPD pa-
tients; which suggest that this increase of bacterial load
in the lower respiratory tract may contribute to acute
exacerbation in COPD. A previous study has indicated
the colonization of Streptococcus pneumoniae in
AECOPD patients [42]. In this present study, there
was no significant increase of Streptococcus pneumo-
niae in PSB and BALF samples from AECOPD pa-
tients, compared with stable COPD patients and HS.
However, our study results had no discrepancy with
previous studies, because high loads of Streptococcus
pneumoniae were found in both stable COPD patients
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and HS; which is consistent with a previous study
[35]. Our results by RT-qPCR indicated that Strepto-
coccus pneumoniae was present in all study subjects,
although previous studies did not detect a high load of
Streptococcus pneumoniae in these subjects by using
conventional culture methods.
In the contrary, diagnosing lower respiratory tract infec-
tions caused by Streptococcus peumoniae, Haemophilus
influenzae, and Moraxella catarrhalis by PCR has been
limited to distinguishing colonization from infections.
This may depend on the analysis that combined the load
of the above pathogens with symptoms and inflammatory
mediators such as C-reactive protein, the number of neu-
trophils, and some pro-inflammatory cytokines. Exacerba-
tions are typically associated with increased neutrophilic
airway inflammation [43, 44]. Pro-inflammatory cytokines
such as TNF-α, IL-1 β and IL-6 are increased in COPD
and appear to amplify inflammation [45]. In this
present study, there was a significant increase in the
number of neutrophils in BALF, and in the levels of
pro-inflammatory cytokines IL-1 β, IL-6, IL-8, IL-10
and TNF-α in BALF supernatants obtained from
AECOPD patients, compared with stable COPD pa-
tients and HS; and there was a positive correlation be-
tween the load of Klebsiella pneumoniae, Haemophilus
influenzeae, Moraxella catarrhalis and Pseudomonos
aeruginosa, and most inflammatory mediators. These
data indicate that the increase in the load of common
pathogens in the lower respiratory tract of COPD patients
may contribute to the increase in pro-inflammatory re-
sponse as acute exacerbations occur, resulting in disease
progression and gradual decline in lung function. Indeed,
there was a negative correlation between the load of the six
pathogens and the FEV1 % predicted, FVC % predicted and
FEV1/FVC values, which revealed that increased loads of
common pathogens led to the decline of lung functions in
COPD patients. However, in this present study, there was
no quantitative data regarding changes in the above bac-
teria in the lower respiratory tract of mild COPD patients
(GOLD stage I). Thus, the association between the load of
these six bacteria and the degree of airflow obstruction in
COPD patients was limited, requiring a more in-depth
study in the future.
Conclusions
In summary, our data indicate that significantly higher
loads of Klebsiella pneumoniae, Haemophilus influen-
zeae, Moraxella catarrhalis, and Pseudomonos aerugi-
nosa exist in PSB and BALF samples obtained from
AECOPD patients, compared with stable COPD patients
and HS, as revealed by RT-qPCR. Higher loads were cor-
related with increased inflammatory response in the
lower respiratory tract, and were associated with disease
progression and decline in lung function in COPD
patients. Our study may provide a new standard for the
quantitative measurement of common bacteria in the
lower respiratory tract of moderate and severe COPD
patients, and provide some guidance in determining the
most appropriate antibiotic therapy for AECOPD pa-
tients. Limitations of this study include small sample
size, lack of healthy smokers and mild COPD patients,
as well as the relationship between bacterial load and
immune barrier of the lower respiratory tract in COPD
patients. Therefore, further studies with a larger patient
population are warranted to address these issues.
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